Vivera Pharmaceuticals, Inc. is an innovative, science-driven pharmaceutical company focused on opioid deterrence and cessation and non-addictive solutions for pain management.

In addition to its pharmaceutical and medical device products, the Company has global exclusivity to license the patented and provisionally patented, TABMELT® sublingual drug-delivery system for pharmaceutical use.

Vivera Pharmaceuticals is seeking to conduct case studies and clinical trials utilizing the TABMELT® drug delivery format.

With multiple divisions, Vivera® is vertically integrated with patented technology, manufacturing capabilities, and distribution for its products.